We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Nuclear Medicine Test Identifies Kidney Transplant Infection

By MedImaging International staff writers
Posted on 28 Nov 2017
Print article
Image: An MRI showing focal restriction of diffusion (A), with corresponding upregulated CXCR4 expression (Photo courtesy of Hannover Medical School).
Image: An MRI showing focal restriction of diffusion (A), with corresponding upregulated CXCR4 expression (Photo courtesy of Hannover Medical School).
A novel positron emission tomography/magnetic resonance imaging (PET/MRI) test can determine whether a kidney transplant patient has developed infection in the transplanted tissue, according to a new study.

Researchers at Hannover Medical School (Germany) conducted a study involving 13 kidney transplant recipients with complicated urinary tract infections (UTIs) in order to determine whether molecularly targeted PET/MRI could enable the detection of leukocytes in renal allografts. The patients underwent both PET with a specific CXCR4 ligand (68Ga-pentixafor), and diffusion-weighted MRI. The spatial distribution and intensity of CXCR4 upregulation in the kidney transplants were analyzed and compared with urinalysis, clinical chemistry and bacteriology, and biopsy (if available).

The study showed that PET/MRI detected acute infection in the transplanted kidneys of nine patients, and lower UTI/non-urological infections in the remaining four patients. Leukocyte infiltration was identified by areas of CXCR4 upregulation versus unaffected parenchyma in PET, corresponding to areas with increased cell density under MRI. Transplant CXCR4 signal was mirrored by similar upregulation in lymphoid organs, and histopathology supported a correlation between CXCR4 signal and presence of leukocytes. The study was published in the November 2017 issue of The Journal of Nuclear Medicine.

“This work establishes CXCR4-targeted PET as a novel approach for imaging of infection, and it strengthens the role of nuclear medicine for renal imaging,” said lead author Thorsten Derlin, MD, of the department of nuclear medicine. “It demonstrates the potential of integrating state-of-the art imaging approaches - i.e., diffusion-weighted MRI and novel, highly specific PET tracers - for a comprehensive assessment of kidney disease, and has the potential to be translated into other settings of difficult-to-diagnose infections, such as cholangitis in transplanted patients and bone infections.”

CXCR-4 is an alpha-chemokine receptor specific for stromal-derived-factor-1 (SDF-1), a molecule with potent chemotactic activity for lymphocytes. After attachment to SDF-1, the CXCR4 protein activates signaling pathways inside the cell that help regulate cell growth and proliferation. CXCR4 is also involved in cell migration, especially that of hematopoietic stem cells in the bone marrow.

Related Links:
Hannover Medical School

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Color Doppler Ultrasound System
DRE Crystal 4PX
New
Ultrasound System
Acclarix AX9
New
Ultrasound Software
UltraExtend NX

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.